Picture of Wntresearch AB logo

WNT Wntresearch AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+4.3%
3m+106.53%
6m+28.73%
1yr-59.28%
Volume Change (%)
10d/3m-34.43%
Price vs... (%)
52w High-70.45%
50d MA+4.43%
200d MA+0.9%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-90.33%
Return on Equity-103.7%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Wntresearch AB EPS forecast chart

Profile Summary

WntResearch AB is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process. As of December 31, 2011, the Company had two projects, namely Foxy-5 and Box-5. Foxy-5 is a hexapeptide mimicking the effects of WNT-5a. Box-5 is a peptide antagonizing the effects of Wnt-5a. As of March 31, 2012, the Company’s largest shareholder was Forskarpatent I Syd AB, which held 26.55% shares.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
September 24th, 2007
Public Since
December 17th, 2010
No. of Employees
2
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
se flag iconAktieTorget Stock Exchange
Shares in Issue
8,660,589.93

WNT Share Price Performance

Upcoming Events for WNT

Similar to WNT

Picture of Abera Bioscience AB logo

Abera Bioscience AB

se flag iconAktieTorget Stock Exchange

Picture of Aptahem AB logo

Aptahem AB

se flag iconAktieTorget Stock Exchange

Picture of Arcede Pharma AB logo

Arcede Pharma AB

se flag iconAktieTorget Stock Exchange

Picture of Carbiotix AB (publ) logo

Carbiotix AB (publ)

se flag iconAktieTorget Stock Exchange

Picture of Chosa Oncology AB logo

Chosa Oncology AB

se flag iconAktieTorget Stock Exchange

FAQ